Geode Capital Management, LLC Inozyme Pharma, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Inozyme Pharma, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,171,172 shares of INZY stock, worth $3.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,171,172

Previous 1,151,673 1.69%

Holding current value

$3.54 Million

Previous $5.14 Million 19.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.31 - $6.0 $84,040 - $116,994	19,499 Added 1.69%	1,171,172 $6.13 Million
Q2 2024 Aug 09, 2024	BUY	$4.33 - $7.31 $364,560 - $615,458	84,194 Added 7.89%	1,151,673 $5.14 Million
Q1 2024 May 13, 2024	BUY	$4.14 - $7.66 $143,918 - $266,284	34,763 Added 3.37%	1,067,479 $8.18 Million
Q4 2023 Feb 13, 2024	BUY	$2.71 - $4.5 $568,810 - $944,518	209,893 Added 25.51%	1,032,716 $4.4 Million
Q3 2023 Nov 13, 2023	BUY	$4.09 - $7.0 $839,938 - $1.44 Million	205,364 Added 33.26%	822,823 $3.46 Million
Q2 2023 Aug 11, 2023	BUY	$4.93 - $6.74 $1.85 Million - $2.54 Million	376,251 Added 155.99%	617,459 $3.44 Million
Q1 2023 May 15, 2023	BUY	$1.3 - $5.73 $10,506 - $46,309	8,082 Added 3.47%	241,208 $1.38 Million
Q4 2022 Feb 13, 2023	SELL	$1.05 - $2.82 $586 - $1,576	-559 Reduced 0.24%	233,126 $244,000
Q3 2022 Nov 14, 2022	BUY	$2.57 - $5.45 $43,073 - $91,342	16,760 Added 7.73%	233,685 $626,000
Q2 2022 Aug 12, 2022	BUY	$3.2 - $5.96 $98,937 - $184,271	30,918 Added 16.62%	216,925 $1.03 Million
Q1 2022 May 13, 2022	BUY	$3.87 - $7.55 $7,693 - $15,009	1,988 Added 1.08%	186,007 $760,000
Q4 2021 Feb 11, 2022	SELL	$5.58 - $11.5 $81,495 - $167,957	-14,605 Reduced 7.35%	184,019 $1.26 Million
Q3 2021 Nov 12, 2021	BUY	$11.12 - $19.4 $210,746 - $367,668	18,952 Added 10.55%	198,624 $2.3 Million
Q2 2021 Aug 13, 2021	BUY	$15.19 - $21.2 $445,234 - $621,393	29,311 Added 19.49%	179,672 $3.06 Million
Q1 2021 May 12, 2021	BUY	$17.77 - $27.9 $780,369 - $1.23 Million	43,915 Added 41.26%	150,361 $2.98 Million
Q4 2020 Feb 12, 2021	BUY	$19.95 - $27.55 $162,831 - $224,863	8,162 Added 8.3%	106,446 $2.2 Million
Q3 2020 Nov 13, 2020	BUY	$17.54 - $30.2 $1.72 Million - $2.97 Million	98,284 New	98,284 $2.58 Million

Others Institutions Holding INZY

# of Institutions

Shares Held

53M

Call Options Held

3.7K

Put Options Held

5.8K

View Full List

About Inozyme Pharma, Inc.

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $121M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

More about INZY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Inozyme Pharma, Inc. Transaction History